- Applied Therapeutics (APLT) -22% on pricing $30M equity offering.
- Xenon Pharmaceuticals (XENE) -13% on pricing $250M equity offering.
- Clovis Oncology (CLVS) -10%
- Zai Lab (ZLAB) -9% on conversion of secondary listing in Hong Kong to primary to take effect June 27.
- Angion Biomedica (ANGN) -8%.
- JX Luxventure (LLL) -7%.